84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]童銘豪,余陽,秦路平,等.基于“一氣周流”理論辨治絕經(jīng)后骨質(zhì)疏松癥[J].中醫(yī)正骨,2022,34(04):58-60.
點擊復(fù)制

基于“一氣周流”理論辨治絕經(jīng)后骨質(zhì)疏松癥()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第34卷
期數(shù):
2022年04期
頁碼:
58-60
欄目:
學(xué)術(shù)探討
出版日期:
2022-04-20

文章信息/Info

作者:
童銘豪1余陽1秦路平2唐彬彬3史曉林3劉康3
(1.浙江中醫(yī)藥大學(xué)第二臨床醫(yī)學(xué)院,浙江 杭州 310053; 2.浙江中醫(yī)藥大學(xué)藥學(xué)院,浙江 杭州 311402; 3.浙江中醫(yī)藥大學(xué)附屬第二醫(yī)院,浙江 杭州 310005)
關(guān)鍵詞:
骨質(zhì)疏松絕經(jīng)后 骨痿 一氣周流 辨證論治
摘要:
絕經(jīng)后骨質(zhì)疏松癥(postmenopausal osteoporosis,PMOP)屬中醫(yī)學(xué)“骨痿”范疇。中醫(yī)學(xué)認(rèn)為,骨痿發(fā)病主要責(zé)之于腎,與心、肝、脾、胃、肺等臟腑功能失調(diào)有關(guān)。但臟腑辨證方法對PMOP的復(fù)雜病機整體把握不足,而清代名醫(yī)黃元御的“一氣周流”理論從“整體觀”出發(fā),可以更好地契合PMOP的病機變化特點。本文介紹了“一氣周流”理論的內(nèi)涵,闡述了PMOP的中醫(yī)發(fā)病機理,從“降胃斂肺,培津益腎”“培植中土,達(dá)木扶陽”“補肝升脾,益腎化瘀”3個方面對基于“一氣周流”理論辨治PMOP進(jìn)行了探討。

參考文獻(xiàn)/References:

[1] 中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會.原發(fā)性骨質(zhì)疏松癥診療指南(2017)[J].中國骨質(zhì)疏松雜志,2019,25(3):281-309.
[2] 《中國老年骨質(zhì)疏松診療指南》(2018年)工作組,中國老年學(xué)和老年醫(yī)學(xué)學(xué)會骨質(zhì)疏松分會.中國老年骨質(zhì)疏松診療指南(2018)[J].中國老年學(xué)雜志,2019,39(11):2557-2579.
[3] 中華中醫(yī)藥學(xué)會.絕經(jīng)后骨質(zhì)疏松癥(骨痿)中醫(yī)藥診療指南(2019年版)[J].中醫(yī)正骨,2020,32(2):1-13.
[4] 周龍云,黃桂成,陳旭青,等.基于生命四時調(diào)理脾胃探析骨質(zhì)疏松癥“治未病”理念[J].中國骨質(zhì)疏松雜志,2016,22(9):1174-1177.
[5] 謝興文,李建國,李寧,等.基于“益腎生髓”理論探討絕經(jīng)后骨質(zhì)疏松癥的病機及臨床治療[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2019,25(11):1635-1636.
[6] 陳易,徐琬梨.基于證素辨證探析絕經(jīng)后骨質(zhì)疏松癥[J].山東中醫(yī)藥大學(xué)學(xué)報,2017,41(2):105-107.
[7] 章瑞斌,王飛,楊詩宏,等.生命存在的基本形式——一氣周流新釋[J].光明中醫(yī),2016,31(20):3014-3015.
[8] 黃元御.四圣心源[M].北京:中國中醫(yī)藥出版社,2009:9-65.
[9] 毛文艷,杜武勛.黃元御一氣周流理論探析[J].江蘇中醫(yī)藥,2016,48(3):6-8.
[10] 周博文.從黃元御“中氣升降”理論探討氣血瘀滯證治[J].中國中醫(yī)藥信息雜志,2017,24(4):115-117.
[11] 李建國,謝興文,李寧,等.絕經(jīng)后骨質(zhì)疏松癥的中醫(yī)臟腑認(rèn)識及治療現(xiàn)狀[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2019,25(3):410-412.
[12] 劉語涵,李莉,梁德,等.圍絕經(jīng)期骨痿探析[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2020,26(1):20-21.
[13] 黃帝內(nèi)經(jīng)素問[M].北京:人民衛(wèi)生出版社,2012:1-190.
[14] 曹盼舉,張曉剛,于海洋,等.基于《內(nèi)經(jīng)》“肺熱葉焦,則生痿躄”理論探討肺與骨質(zhì)疏松癥之間的關(guān)系[J].中國骨質(zhì)疏松雜志,2019,25(5):709-712.
[15] 邸貴鑫,楊芳.從中醫(yī)五臟論骨質(zhì)疏松癥病機[J].遼寧中醫(yī)藥大學(xué)學(xué)報,2021,23(10):84-87.
[16] 張雯迪,岳東輝.中醫(yī)玄府學(xué)說內(nèi)涵探析[J].中華中醫(yī)藥雜志,2021,36(6):3216-3218.
[17] 歐飛微,熊曼玲,解麗菲,等.從“肝腎同源”探討絕經(jīng)后骨質(zhì)疏松癥的發(fā)病機制[J].遼寧中醫(yī)雜志,2021,48(7):52-56.
[18] 鄒厚輝,范超領(lǐng),葛繼榮.從肝論治原發(fā)性骨質(zhì)疏松癥的研究進(jìn)展[J].中國骨質(zhì)疏松雜志,2016,22(6):766-770.
[19] 李建國,謝興文,李寧,等.基于“肝藏血主疏泄”理論探討絕經(jīng)后骨質(zhì)疏松癥的病因病機[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2019,25(9):1203-1206.
[20] 吳秋玲,嚴(yán)儼,白兆芝.中醫(yī)胃衰老之初探[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2005,11(6):407.
[21] 周龍云,郭楊,黃桂成,等.骨質(zhì)疏松癥“病本在脾,以陰陽兩虛為要”之見探討[J].中國骨質(zhì)疏松雜志,2016,22(4):487-491.

相似文獻(xiàn)/References:

[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的 胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]李學(xué)朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
 LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):12.
[3]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng) 在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[4]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
 Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):27.
[5]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證 患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
 Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(04):19.
[6]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
 Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(04):20.
[7]史曉林,李春雯,張志強.弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
 Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
 Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的 相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
 CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(04):16.
[10]許超,肖魯偉,吳承亮.絕經(jīng)后女性骨質(zhì)疏松癥辨證分型與抑郁焦慮的關(guān)系研究[J].中醫(yī)正骨,2011,23(12):3.
 XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(04):3.
[11]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
 HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):7.
[12]歐國峰,劉鑫,董博,等.絕經(jīng)后骨質(zhì)疏松癥的免疫學(xué)研究進(jìn)展[J].中醫(yī)正骨,2016,28(08):70.
[13]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
 SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(04):1.
[14]梁文娜,李西海,李燦東.血清microRNA與絕經(jīng)后骨質(zhì)疏松癥腎虛證的關(guān)系[J].中醫(yī)正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制絕經(jīng)后骨質(zhì)疏松大鼠骨代謝紊亂的作用機制研究[J].中醫(yī)正骨,2017,29(11):1.
 LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(04):1.
[16]劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學(xué)概況及發(fā)病機制研究進(jìn)展[J].中醫(yī)正骨,2018,30(03):52.
[17]楊依然,劉鐘,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳動物雷帕霉素靶蛋白通路參與絕經(jīng)后骨質(zhì)疏松癥發(fā)生發(fā)展過程中細(xì)胞自噬的機制[J].中醫(yī)正骨,2018,30(04):59.
[18]曹俊青,鄭劍南,張麟.右歸丸聯(lián)合阿侖膦酸鈉口服治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證的臨床研究[J].中醫(yī)正骨,2018,30(05):20.
 CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右歸丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(04):20.
[19]李中萬,徐紹俊,楊廣鋼,等.健腎方聯(lián)合碳酸鈣D3咀嚼片(Ⅱ) 治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證[J].中醫(yī)正骨,2018,30(08):11.
 LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健腎方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(04):11.
[20]趙凡,劉全,吳連國.口服強骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(04):26.
 ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(強骨飲)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(04):26.

更新日期/Last Update: 1900-01-01